A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 5 September 2017 |
| Author/s |
author: Jeremy Hoog Obi Griffith Erica K Barnell Tina J Hieken Matthew P Goetz Vera J Suman Charles Erlichman Elaine Mardis Kilannin Krysiak Zachary L Skidmore Malachi Griffith |
| Publication date | September 5, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |